Walleye Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Sell |
3,955
-65,950
| -94% | -$8.28M | ﹤0.01% | 1069 |
|
|
2025
Q1 | $9.57M | Buy |
69,905
+59,865
| +596% | +$8.19M | 0.04% | 224 |
|
|
2024
Q4 | $1.54M | Buy |
10,040
+5,387
| +116% | +$824K | ﹤0.01% | 795 |
|
|
2024
Q3 | $902K | Sell |
4,653
-42,642
| -90% | -$8.27M | ﹤0.01% | 1083 |
|
|
2024
Q2 | $11M | Buy |
47,295
+37,711
| +393% | +$8.74M | 0.02% | 245 |
|
|
2024
Q1 | $2.07M | Buy |
+9,584
| New | +$2.07M | ﹤0.01% | 763 |
|
|
2023
Q4 | – | Sell |
-1,438
| Closed | -$370K | – | 2226 |
|
|
2023
Q3 | $370K | Sell |
1,438
-13,250
| -90% | -$3.41M | ﹤0.01% | 1246 |
|
|
2023
Q2 | $4.18M | Buy |
14,688
+994
| +7% | +$283K | 0.02% | 335 |
|
|
2023
Q1 | $3.81M | Sell |
13,694
-20,803
| -60% | -$5.78M | 0.06% | 355 |
|
|
2022
Q4 | $9.55M | Buy |
+34,497
| New | +$9.55M | 0.17% | 123 |
|
|
2022
Q2 | – | Sell |
-1,685
| Closed | -$355K | – | 2312 |
|
|
2022
Q1 | $355K | Buy |
+1,685
| New | +$355K | 0.01% | 1164 |
|
|
2020
Q2 | – | Sell |
-180
| Closed | -$57K | – | 606 |
|
|
2020
Q1 | $57K | Sell |
180
-30
| -14% | -$9.5K | 0.01% | 415 |
|
|
2019
Q4 | $62K | Sell |
210
-3,342
| -94% | -$987K | ﹤0.01% | 516 |
|
|
2019
Q3 | $827K | Buy |
3,552
+3,392
| +2,120% | +$790K | 0.05% | 58 |
|
|
2019
Q2 | $37K | Buy |
+160
| New | +$37K | ﹤0.01% | 344 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 402 |
|
|
2018
Q3 | $562K | Buy |
+1,591
| New | +$562K | 0.26% | 103 |
|